Solid compositions
Granted 24 Mar 2015 · 2 office actions
Assignee: AbbVie Inc.
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Geoff Zhang, Yi Gao · Examiner: Ernst V Arnold · AU 1613 · TC 1600
Life of the patent
4 dated eventsAbstract
The present invention features solid compositions comprising a selected HCV inhibitor in an amorphous form. In one embodiment, the selected HCV inhibitor is formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.
Claims
1 · 1 independent · depth 1Classifications
22 codes- A61K9/16
- A61K31/501
- A61K31/4184
- A61K38/05
- A61K31/4178
- A61K9/14
- A61K31/708
- A61K31/439
- A61K9/10
- A61K31/403
- A61K38/06
- A61K38/07
- A61K31/55
- A61K31/519
- A61K31/7068
- A61K31/4709
- A61K31/549
- A61K47/32
- A61K31/497
- A61K45/06
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
2 priority documents›Priority documents — 2
| Type | Document | Date |
|---|---|---|
| provisional | US 61581146 | 29 Dec 2011 |
| related publication | US 20150025024 A1 | 22 Jan 2015 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock